FDA announces firm distributing Chinese-made plastic syringes in the U.S. initiates recall
The Food and Drug Administration May 23 announced that Medline Industries, a firm marketing and distributing Chinese-manufactured plastic syringes within the U.S., initiated a recall to stop using affected products, including unauthorized plastic syringes made in China. On Tuesday, Chinese manufacturer Jiangsu Shenli Medical Production Co. initiated a recall to stop using its unauthorized syringes. The FDA last week recommended users immediately transition away from plastic syringes made by Jiangsu Shenli Medical Production Co., along with those made by Jiangsu Caina Medical Co., Zhejiang Longde Pharmaceutical Co. and Shanghai Kindly Enterprise Development Group Co.
Related News Articles
Headline
The Food and Drug Administration yesterday announced an import alert for plastic syringes manufactured by two China-based manufacturers, in addition to…
Headline
The Food and Drug Administration May 9 released final guidance clarifying the definition of “remanufacturing” for reusable medical devices needing…
Headline
U.S. health care organizations should immediately transition away from using certain unauthorized plastic syringes made in China by Jiangsu Caina Medical Co.…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
In updated guidance for makers of medical devices labeled as sterile, the Food and Drug Administration Jan. 8 listed vaporized hydrogen peroxide as an…
Headline
The Food and Drug Administration the week of July 24 updated its recognized consensus standards database for medical devices to advance innovation in medical…